Between May 1, 1986 and May 31, 1992 at the University of Minnesota, w
e interpreted 129 renal allograft biopsy specimens (done in 48 grafts
during the first 6 months posttransplant) as showing changes consisten
t with chronic rejection, For this retrospective analysis, we reexamin
ed these biopsies together with clinical information to determine: (a)
whether a diagnosis other than chronic rejection would have been more
appropriate, (b) how early posttransplant any chronic rejection chang
es occurred, and (c) if the diagnosis correlated with outcome. We foun
d that (1) chronic rejection is uncommon in the first 6 months posttra
nsplant; it was documented in only 27 (2.4%) of 1117 renal allografts
and was preceded by acute rejection in all but 3 recipients (for these
3, the first biopsy specimen showed both acute and chronic rejection)
, (2) Chronic vascular rejection was seen in 1 recipient as early as 1
month posttransplant; the incidence increased over time and was assoc
iated with an actual graft survival rate of only 35%, (3) The most fre
quent cause of arterial intimal fibrosis in the first 6 months posttra
nsplant was arteriosclerotic nephrosclerosis (ASNS) of donor origin, L
ongterm graft function for recipients with ASNS was 67%, (4) Early-ons
et ischemia or thrombosis was seen in 14 recipients and predicted poor
outcome: only 35.7% of these recipients had long-term graft function,
(5) Cyclosporine (CsA) toxicity was implicated in only 3 recipients,
who had mild diffuse interstitial fibrosis in association with elevate
d CsA levels. Other variables (including systemic hypertension, urinar
y tract infection, obstructive uropathy, neurogenic bladder, cobalt th
erapy, and recurrent disease) were not significantly associated with c
hronic renal lesions in the first 6 months posttransplant. A significa
nt number of biopsies were originally interpreted as showing chronic r
ejection, but the diagnosis was changed upon reevaluation in conjuncti
on with clinical data,We conclude that many factors coexist to produce
chronic lesions in biopsies during the first 6 months posttransplant,
so clinical correlation is needed before establishing a diagnosis of
chronic rejection.